A cross-sectional study on the relationship between depression and left ventricular hypertrophy

Y Takemura1, S Kikuchi, H Takagi

  • 1Department of Epidemiology and Environmental Health, Juntendo University School of Medicine, Tokyo, Japan.

Preventive Medicine
|January 28, 1999
PubMed

Insights

High depression levels are linked to a greater risk of left ventricular hypertrophy (LVH), a heart condition. This finding suggests depression may be a factor in cardiovascular disease prevention.

Area of Science:

  • Cardiology
  • Psychiatry
  • Preventive Medicine

Background:

  • The link between depression and cardiovascular disease (CVD) is not fully understood.
  • Left ventricular hypertrophy (LVH), detected by electrocardiogram (ECG), is a significant CVD risk factor.
  • This study explores the novel association between depression and ECG-detected LVH.

Purpose of the Study:

  • To investigate the relationship between depression and left ventricular hypertrophy (LVH).
  • To determine if depression is an independent risk factor for LVH in middle-aged men.

Main Methods:

  • 346 male participants aged 49-55 from Japan Self-Defense Forces.
  • Assessment of LVH using electrocardiogram (ECG).
  • Measurement of depression via the Self-Rating Depression Scale (SDS).
  • Logistic regression analysis adjusted for BMI, systolic, and diastolic blood pressure.

Main Results:

  • A high depression level (SDS score ≥ 34) was associated with an increased risk of LVH.
  • A trend towards a positive association between LVH and high depression levels persisted after adjusting for cardiovascular risk factors.

Conclusions:

  • Depression is closely associated with left ventricular hypertrophy (LVH).
  • LVH is a predictor of fatal cardiovascular events, highlighting the importance of managing depression for heart health.
  • Findings support the integration of mental health screening and intervention in cardiovascular disease prevention strategies.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...